Literature DB >> 27867187

Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.

Nan Zheng1, Lu Liu1, Wei-Wei Liu1, Fei Li1, Toshihiko Hayashi1, Shin-Ichi Tashiro2, Satoshi Onodera3, Takashi Ikejima1.   

Abstract

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) play important roles in regulating cell survival and death. Silibinin is a natural polyphenolic flavonoid isolated from milk thistle with anti-tumor activities, but it was found to induce cytoprotective ROS/RNS in human breast cancer MCF-7 cells. Furthermore, treatment with silibinin down-regulates ERα expression in MCF-7 cells, and inducing both autophagy and apoptosis. In this study we explored the relationship between ER-associated pathways and RNS/ROS in MCF-7 cells. We also investigated the molecular mechanisms underlying the reciprocal regulation between ROS/RNS levels and autophagy in the death signaling pathways in silibinin-treated MCF-7 cells. Silibinin (100-300 μmol/L) dose-dependently increased ROS/RNS generation in MCF-7 cells (with high expression of ERα and low expression of ERβ) and MDA-MB-231 cells (with low expression of ERα and high expression of ERβ). Scavenging ROS/RNS significantly enhanced silibinin-induced death of MCF-7 cells, but not MDA-MB231 cells. Pharmacological activation or blockade of ERα in MCF-7 cells significantly enhanced or decreased, respectively, silibinin-induced ROS/RNS generation, whereas activation or block of ERβ had no effect. In silibinin-treated MCF-7 cells, exposure to the ROS/RNS donators decreased the autophagic levels, whereas inhibition of autophagy with 3-MA significantly increased ROS/RNS levels. We further showed that increases in ROS/RNS generation, ERα activation or autophagy down-regulation had protective roles in silibinin-treated MCF-7 cells. Under a condition of ERα activation, scavenging ROS/RNS or stimulating autophagy enhanced the cytotoxicity of silibinin. These results demonstrate the existence of two conflicting pathways in silibinin-induced death of MCF-7 cells: one involves the down-regulation of ERα and thereby augmenting the pro-apoptotic autophagy downstream, leading to cell death; the other involves the up-regulation of pro-survival ROS/RNS; and that the generation of ROS/RNS and autophagy form a negative feedback loop whose balance is regulated by ERα.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27867187      PMCID: PMC5309753          DOI: 10.1038/aps.2016.117

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  43 in total

1.  Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes.

Authors:  Shigeomi Shimizu; Toku Kanaseki; Noboru Mizushima; Takeshi Mizuta; Satoko Arakawa-Kobayashi; Craig B Thompson; Yoshihide Tsujimoto
Journal:  Nat Cell Biol       Date:  2004-11-21       Impact factor: 28.824

Review 2.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

3.  MCF-7 breast carcinoma cells do not express caspase-3.

Authors:  Reiner U Jänicke
Journal:  Breast Cancer Res Treat       Date:  2008-10-14       Impact factor: 4.872

4.  Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.

Authors:  Soo Ok Lee; Nagalakshmi Nadiminty; Xiu Xian Wu; Wei Lou; Yan Dong; Clement Ip; Sergio A Onate; Allen C Gao
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.

Authors:  Mercedes Nadal-Serrano; Jorge Sastre-Serra; Daniel Gabriel Pons; Antonia María Miró; Jordi Oliver; Pilar Roca
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

6.  Silibinin induced-autophagic and apoptotic death is associated with an increase in reactive oxygen and nitrogen species in HeLa cells.

Authors:  Simiao Fan; Lihua Li; Shengeng Chen; Yang Yu; Min Qi; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Free Radic Res       Date:  2011-10-21

7.  Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.

Authors:  Mercedes Nadal-Serrano; Daniel Gabriel Pons; Jorge Sastre-Serra; M del Mar Blanquer-Rosselló; Pilar Roca; Jordi Oliver
Journal:  Int J Biochem Cell Biol       Date:  2013-07-17       Impact factor: 5.085

8.  Autophagy, not apoptosis, is essential for midgut cell death in Drosophila.

Authors:  Donna Denton; Bhupendra Shravage; Rachel Simin; Kathryn Mills; Deborah L Berry; Eric H Baehrecke; Sharad Kumar
Journal:  Curr Biol       Date:  2009-10-08       Impact factor: 10.834

9.  Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus.

Authors:  Zhican Wang; Gihani T Wijewickrama; Kuan-Wei Peng; Birgit M Dietz; Long Yuan; Richard B van Breemen; Judy L Bolton; Gregory R J Thatcher
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

10.  Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway.

Authors:  Subash C Gupta; Ramesh Singh; Radhika Pochampally; Kounosuke Watabe; Yin-Yuan Mo
Journal:  Oncotarget       Date:  2014-12-15
View more
  9 in total

Review 1.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 2.  Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Roman Lysiuk; Antonio Vella; Larysa Lenchyk; Taras Upyr
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

3.  Crosstalk Influence between P38MAPK and Autophagy on Mitochondria-Mediated Apoptosis Induced by Anti-Fas Antibody/Actinomycin D in Human Hepatoma Bel-7402 Cells.

Authors:  Yu Wang; Chunhui Xia; Yanxin Lv; Chengjun Li; Qingbu Mei; Hongmei Li; Haijun Wang; Shuang Li
Journal:  Molecules       Date:  2017-10-17       Impact factor: 4.411

4.  Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells.

Authors:  Xiaokun Lin; Lei Han; Jialei Weng; Kelai Wang; Tongke Chen
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

5.  Licochalcone A Inhibits Cellular Motility by Suppressing E-cadherin and MAPK Signaling in Breast Cancer.

Authors:  Wen-Chung Huang; Haiso-Han Su; Li-Wen Fang; Shu-Ju Wu; Chian-Jiun Liou
Journal:  Cells       Date:  2019-03-05       Impact factor: 6.600

6.  Differential Effects of Silibinin A on Mitochondrial Function in Neuronal PC12 and HepG2 Liver Cells.

Authors:  Carsten Esselun; Bastian Bruns; Stephanie Hagl; Rekha Grewal; Gunter P Eckert
Journal:  Oxid Med Cell Longev       Date:  2019-11-23       Impact factor: 6.543

Review 7.  Flavonoids Regulate Inflammation and Oxidative Stress in Cancer.

Authors:  Guangxing Li; Kaiyue Ding; Yanling Qiao; Liu Zhang; Luping Zheng; Taowen Pan; Lin Zhang
Journal:  Molecules       Date:  2020-11-30       Impact factor: 4.411

8.  Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets.

Authors:  Ali Pourgholi; Mehdi Dadashpour; Akram Mousapour; Akram Firouzi Amandi; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2021-08-01

9.  Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.

Authors:  Saba Sameri; Chiman Mohammadi; Mehrnaz Mehrabani; Rezvan Najafi
Journal:  BMC Complement Med Ther       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.